Article

Probiotic Mix has Benefits in Relapsing Ulcerative Colitis

Adding a high-potency probiotic mix may improve the clinical picture of patients with ulcerative colitis on immunosuppresive therapy.

This video features discussion of a study that found that the addition of a high-potency probiotic mixture to the treatment regimen of patients with relapsing mild-to-moderate ulcerative colitis on immunosuppressive therapy may “improve the clinical picture” and allow these patients to avoid a new course of steroids.

Click here to access this third-party resource.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
© 2024 MJH Life Sciences

All rights reserved.